Clinical Trial Update: A Study of Adalimumab to Treat Sarcoidosis of the Skin [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adalimumab for sarcoidosis of the skin has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoidosis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Pariser, Robert J., M.D. | Conditions: Sarcoidosis | Phase 2 | Status: COMPLETED